Post by ROTOP Pharmaka GmbH

A major step forward for #ROTOP: we’ve received the 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗽𝗲𝗿𝗺𝗶𝘁 for our 𝗻𝗲𝘄 𝗿𝗮𝗱𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗳𝗮𝗰𝗶𝗹𝗶𝘁𝘆 in Dresden. With the upcoming 𝗥𝗢𝗧𝗢𝗣 𝗖𝗠𝗢 𝗖𝗲𝗻𝘁𝗲𝗿, we are expanding our CDMO capabilities to support Phase III and commercial supply of radiopharmaceutical therapies – including radioligand therapies. As more programs move into late-stage development, reliable manufacturing and supply become a critical bottleneck. This investment is designed to help our partners scale efficiently and transition from clinical development into commercial production. Located in Dresden and close to the DHL hub in Leipzig, the site is built for time-sensitive, just-in-time delivery of radiopharmaceutical therapies. The permit was officially handed over today at Dresden Tomorrow's Home (Wirtschaftsförderung Dresden). Thank you to our teams, partners, investors, and regional stakeholders for making this possible. More updates to follow as the project progresses. For full press release: https://lnkd.in/djKFzYA7 #Radiopharmaceuticals #CDMO #RadioligandTherapy #PharmaManufacturing #Oncology #Dresden #LifeSciences